Results 161 to 170 of about 9,752 (200)

Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review. [PDF]

Osteoporos Int
Abdalbary M, Abdalbary M, Amin AM, Elaraby A, Hassan A.   +4 more
europepmc   +1 more source

Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization. [PDF]

Clin Interv Aging
Li S, Hu S, Zheng X, Ku X, Zou J, Wang L, Nie G, Liu Y, Tian C, Ran J, Yang X, Yan M, Yin Y, Liu Y, Wan J, Peng W.   +15 more
europepmc   +1 more source

Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis. [PDF]

J Orthop Surg Res
Su P, Li M, Xiao J, Bai L.
europepmc   +1 more source

Effectiveness and safety of denosumab monotherapy in patients with primary hyperparathyroidism: A retrospective study. [PDF]

Medicine (Baltimore)
Okada A, Baba R, Ishibashi Y, Otagaki Y, Kodama T, Egusa G, Nagano G, Matsuda T, Hattori N, Ohno H.   +9 more
europepmc   +1 more source

Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.

J Clin Endocrinol Metab
Ferrari S, Betah D, Feldman RG, Langdahl BL, Oates M, Timoshanko J, Wang Z, Dhaliwal R.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

[New bone density conservation agents for osteoporosis under research and development: Ibandronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Ikuko, Tanaka, Junko, Hashimoto, Hisaji, Oshima   +2 more
openaire   +1 more source

[Process in development of PTH, an awaited bone-density conservation agent].

, 2012
Toshitsugu Sugimoto
openalex